Prevention of neural tube defects in an urban health district.
- 1 September 1983
- journal article
- research article
- Published by BMJ in Journal of Epidemiology and Community Health
- Vol. 37 (3) , 221-225
- https://doi.org/10.1136/jech.37.3.221
Abstract
An evaluation of voluntary prenatal screening for neural tube defects [NTD] with serum .alpha.-fetoprotein (s-AFP) is presented. During a 3 yr period, there were 52 fetuses with neural lesions. Of 46 mothers who bore a fetus with an open neural lesion, 25 were detected, of whom 23 agreed to the termination of their pregnancies. An unscreened group of 2331 mothers (17% of all deliveries) produced 14 fetuses with neural tube defects, an incidence of 6.0/1000, 1.8 times the incidence (3.3/1000) in the screened group. Pitfalls occurring in the assessment of hyper-.alpha.-fetoproteinemia included inaccurate gestational dating and allowance for excessive body weight. The results of a robost AFP-NTD screening program supported in selected cases by ultrasonar visualization of the spine argue for its continuance in this district.This publication has 7 references indexed in Scilit:
- PRENATAL DETECTION OF NEURAL-TUBE DEFECTS BY MATERNAL SERUM ALPHAFETOPROTEIN ASSAY - A PILOT-STUDY USING ENZYME-LINKED IMMUNOSORBENT-ASSAY1981
- Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester.Clinical Chemistry, 1981
- Maternal serum alphafetoprotein in pregnancy and the prevention of birth defect.BMJ, 1980
- Precision in estimating gestational age and its influence on sensitivity of alphafetoprotein screening.BMJ, 1979
- An Optimised Radioimmunoassay for mAternal Serum α1-Fetoprotein using Polyethylene GlycolAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1978
- DIAGNOSTIC REAGENTS FOR ALPHA-FETOPROTEINThe Lancet, 1976